Organoid and Minibioreactor Array Cultivation Core
Organoid and Minibioreactor Array Cultivation Core
批准号:
9915900
负责人:
SARAH E BLUTT
金额:
$17.2万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAgeAnaerobic BacteriaAnimal ModelBacteriaBiologicalBiological ModelsBiopsyBioreactorsCategoriesCell LineCoculture TechniquesCommunicable DiseasesCommunicationCommunitiesComplexCost SavingsDigestive System DisordersDiseaseElementsEnsureEnteralEpithelialEpitheliumEquipment and SuppliesEthnic OriginEvolutionFreezingFunctional disorderFundingGenerationsGenesGeneticGenomic Centers for Infectious DiseasesGenomicsGoalsGrowthGrowth FactorHumanHuman ResourcesImmune responseIn VitroIndividualInfectionIntestinesKnowledgeLeadLeadershipLungMaintenanceMeasuresMedical centerMicrobeModelingMucous MembraneNational Institute of Allergy and Infectious DiseaseOperative Surgical ProceduresOrganismOrganoidsOutcomePathogenesisPathogenicityPatientsPhysiologicalPhysiologyPre-Clinical ModelQuality ControlReagentReproducibilityResearch PersonnelResearch Project GrantsRespiratory Tract DiseasesSamplingSeveritiesSpecimenStandardizationSurfaceSystemTechnologyTechnology TransferTestingTexasTimeTrainingTranslatingUnited States National Institutes of HealthValidationViralVirusWorkairway epitheliumbacterial communitybeneficial microorganismcell typecostcost effectivedemographicsexperimental studygastrointestinalgastrointestinal epitheliumgenome sequencinghuman diseaseimprovedintestinal epitheliummembermicrobial communitymicrobiomemutantnovelnovel strategiespathogenpreventresponsesexsuccess
中文摘要
项目总结
U19传染病基因组中心(GCID)应用程序的目标之一是使用最新的
ART平台,解决围绕多种NIAID A-C类细菌、病毒、真菌、
以及引起胃肠道、肠外和呼吸道疾病的寄生粘膜病原体。至
为了实现这一目标,有机和微型生物反应器阵列培养(OMAC)核心的建立将使
提供关键的生物学意义上相关的人体器官类型和细菌培养,这些培养对
项目的成功。核心将围绕三个目标进行组织:1)生成、维护和提供
实验准备好的肠道和呼吸道有机培养物和专门的生长试剂可供使用,(2)
从肠道和肺部培养各种类型的微生物群落;(3)建立和监督
利用厌氧平台进行实验,以促进微生物和有机物的共培养。这些目标将
提供通过体外验证获得的关键结果来转换基因组分析的能力
测序研究。核心将减少劳动力、供应和设备成本,并减少完成所需的时间
通过集中隔离、生长和维护类有机物和复合微生物的项目
社区。培养有机物和细菌所需材料的批量获取标准化
含有生长因子和生物反应器的条件培养基及集中维护
管线和生物反应器为各个项目调查员节省了大量的时间和成本
确保标准化和重现性。此外,OMAC核心将增强通信和
项目之间取得的成果的可比性。OMAC核心将是
这个应用程序中每个项目的成功以及将它们连接在一起的统一要素。
英文摘要
PROJECT SUMMARY
One of the goals of this U19 Genomic Center for Infectious Disease (GCID) application is to use state-of-the-
art platforms to address gaps in knowledge surrounding multiple NIAID Category A-C bacterial, viral, fungal,
and parasitic mucosal pathogens that cause gastrointestinal, extraintestinal, and respiratory tract diseases. To
meet this goal, the establishment of the Organoid and Minibioreactor Array Cultivation (OMAC) core will allow
the provision of critical biologically relevant human organotypic and bacterial cultures that are essential for the
success of the project. The core will be organized around three goals: 1) generate, maintain, and provide
experimentally ready intestinal and airway organoid cultures and specialized growth reagents for use, (2)
cultivate various types of microbial communities from the intestine and lung, and (3) establish and oversee
experiments with an anaerobic platform to facilitate co-culture of microbes and organoids. These goals will
offer the ability to translate genomic analysis through in vitro validation of key outcomes obtained from
sequencing studies. The core will reduce labor, supply and equipment costs, and time required to complete
projects by centralizing the isolation, growth, and maintenance of the organoid lines and complex microbial
communities. Bulk acquisition of materials required to culture organoids and bacteria, standardization of
conditioned media containing growth factors and bioreactor media, and centralization of the maintenance of
the lines and bioreactors results in significant time and cost savings to the individual Project investigators and
ensures standardization and reproducibility. Additionally, the OMAC core will enhance communication and
comparability of results obtained between projects. The OMAC core will be an essential component of the
success of each of the projects in this application as well as a unifying element in connecting them together.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Organoid Cultivation Core
-
批准号:10583461
-
项目类别:
-
资助金额:$25.96万
-
财政年份:2021
-
负责人:SARAH E BLUTT
-
依托单位:
Organoid Cultivation Core
-
批准号:10357967
-
项目类别:
-
资助金额:$40.04万
-
财政年份:2021
-
负责人:SARAH E BLUTT
-
依托单位:
Organoid and Minibioreactor Array Cultivation Core
-
批准号:10601136
-
项目类别:
-
资助金额:$55.71万
-
财政年份:2019
-
负责人:SARAH E BLUTT
-
依托单位:
Organoid and Minibioreactor Array Cultivation Core
-
批准号:10160784
-
项目类别:
-
资助金额:$16.98万
-
财政年份:2019
-
负责人:SARAH E BLUTT
-
依托单位:
Organoid and Minibioreactor Array Cultivation Core
-
批准号:10396595
-
项目类别:
-
资助金额:$55.71万
-
财政年份:2019
-
负责人:SARAH E BLUTT
-
依托单位:
Human Biomimetic Scientific Core
-
批准号:10642940
-
项目类别:
-
资助金额:$33.83万
-
财政年份:2015
-
负责人:SARAH E BLUTT
-
依托单位:
Human Biomimetic Scientific Core
-
批准号:10192206
-
项目类别:
-
资助金额:$23.53万
-
财政年份:2015
-
负责人:SARAH E BLUTT
-
依托单位:
Human Biomimetic Scientific Core
-
批准号:10462789
-
项目类别:
-
资助金额:$24.29万
-
财政年份:2015
-
负责人:SARAH E BLUTT
-
依托单位:
Immune Mechansims of Rotavirus Protection & Clearanace
-
批准号:6423066
-
项目类别:
-
资助金额:$4.62万
-
财政年份:2002
-
负责人:SARAH E BLUTT
-
依托单位:
Gastrointestinal Experimental Model Systems Core
-
批准号:10576214
-
项目类别:
-
资助金额:$17.02万
-
财政年份:2001
-
负责人:SARAH E BLUTT
-
依托单位:
Immune Mechansims of Rotavirus Protection & Clearance
-
批准号:6340149
-
项目类别:
-
资助金额:$4.02万
-
财政年份:2001
-
负责人:SARAH E BLUTT
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: